Contralateral pulmonary resection with drug-induced thrombocytopenia after previous lobectomy in chest trauma: a case report.
Secondary pulmonary resection remains challenging because of the risk of serious complications.
APA
Kim DW, Lee KS, et al. (2026). Contralateral pulmonary resection with drug-induced thrombocytopenia after previous lobectomy in chest trauma: a case report.. Journal of trauma and injury. https://doi.org/10.20408/jti.2025.0157
MLA
Kim DW, et al.. "Contralateral pulmonary resection with drug-induced thrombocytopenia after previous lobectomy in chest trauma: a case report.." Journal of trauma and injury, 2026.
PMID
41906464
Abstract
Secondary pulmonary resection remains challenging because of the risk of serious complications. A second thoracic surgical procedure in elective settings should prioritize the patient's recovery potential and functional status. In thoracic oncology, clinical outcomes can be acceptable in selected patients. However, when vital signs are unstable due to traumatic lung injury, selection is not the primary consideration and emergency surgery is required. Thrombocytopenia is a condition in which a patient's platelet count is abnormally low, diagnosed by complete blood count. In humans, the normal platelet count generally ranges from 150,000 to 450,000 platelets/μL of blood. In posttraumatic patients, thrombocytopenia is often difficult to manage because its causes are diverse. To our knowledge, survival after secondary contralateral lung resection in a patient with thrombocytopenia who previously underwent lobectomy for lung cancer is extremely rare.
같은 제1저자의 인용 많은 논문 (5)
- Which Dermal Filler is Better for Penile Augmentation for Aesthetic Purposes? A Prospective, Single-Surgeon Study Based on Real-World Experience.
- Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography.
- 18 F-PSMA-1007 and 18 F-FDG PET/CT Findings of Pulmonary Tuberculosis Mimicking Malignancy.
- Erratum: Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: A Phase I Study.
- Correction: Real time chemosensitivity assay for pancreatic adenocarcinoma.